These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17880772)

  • 21. Vitamin D serum levels in children with vernal keratoconjunctivitis and disease control.
    Ghiglioni DG; Bruschi G; Gandini S; Osnaghi S; Peroni D; Marchisio P
    Int J Immunopathol Pharmacol; 2019; 33():2058738419833468. PubMed ID: 30843446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
    Keklikci U; Dursun B; Cingu AK
    Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH; Tabbara KF
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
    De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
    Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].
    Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T
    J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis].
    Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic options in vernal keratoconjunctivitis].
    Messmer EM
    Ophthalmologe; 2009 Jun; 106(6):557-61. PubMed ID: 19430798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.
    el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V
    Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine.
    Modugno RL; Scalora T; Bonaldo A; Lazzarini D; Leonardi A
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1599-1605. PubMed ID: 32275180
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
    Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
    Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors.
    Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M
    Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis.
    Çoban-Karataş M; Özkale Y; Altan-Yaycıoğlu R; Sızmaz S; Pelit A; Metindoğan S; Cantürk-Uğurbaş S; Aydın-Akova Y
    Turk J Pediatr; 2014; 56(4):410-7. PubMed ID: 25818961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.
    Esposito S; Fior G; Mori A; Osnaghi S; Ghiglioni D
    Paediatr Drugs; 2016 Oct; 18(5):347-55. PubMed ID: 27461427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D levels in children affected by vernal keratoconjunctivitis.
    Zicari AM; Cafarotti A; Occasi F; Lollobrigida V; Nebbioso M; Pecorella I; De Castro G; Spalice A; Loffredo L; Villa MP; Duse M
    Curr Med Res Opin; 2017 Feb; 33(2):269-274. PubMed ID: 27786545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.